Nakamura H, Izumoto Y, Kambe H, Kuroda T, Mori T, Kawamura K, Yamamoto H, Kishimoto T: Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem. 1994, 269 (40): 25143-25149.
CAS
PubMed
Google Scholar
Nakamura H, Kambe H, Egawa T, Kimura Y, Ito H, Hayashi E, Yamamoto H, Sato J, Kishimoto S: Partial purification and characterization of human hepatoma-derived growth factor. Clin Chim Acta. 1989, 183 (3): 273-284. 10.1016/0009-8981(89)90361-6.
Article
CAS
PubMed
Google Scholar
Abouzied MM, El-tahir HM, Prenner L, Haberlein H, Gieselmann V, Franken S: Hepatoma-derived Growth Factor:Significance of Amino Acid Residues 81-100 in Cell Surface Interaction and Proliferative Activity. J Biol Chem. 2005, 280 (12): 10945-10954. 10.1074/jbc.M414652200.
Article
CAS
PubMed
Google Scholar
Everett AD, Bushweller J: Hepatoma derived growth factor is a nuclear targeted mitogen. Curr Drug Targets. 2003, 4 (5): 367-371. 10.2174/1389450033490975.
Article
CAS
PubMed
Google Scholar
Everett AD, Stoops T, McNamara CA: Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells. J Biol Chem. 2001, 276 (40): 37564-37568. 10.1074/jbc.M105109200.
Article
CAS
PubMed
Google Scholar
Kishima Y, Yamamoto H, Izumoto Y, Yoshida K, Enomoto H, Yamamoto M, Kuroda T, Ito H, Yoshizaki K, Nakamura H: Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem. 2002, 277 (12): 10315-10322. 10.1074/jbc.M111122200.
Article
CAS
PubMed
Google Scholar
Abouzied MM, Baader SL, Dietz F, Kappler J, Gieselmann V, Franken S: Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity. Biochem J. 2004, 378 (Pt 1): 169-176.
Article
CAS
PubMed
PubMed Central
Google Scholar
Enomoto H, Yoshida K, Kishima Y, Kinoshita T, Yamamoto M, Everett AD, Miyajima A, Nakamura H: Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation. Hepatology. 2002, 36 (6): 1519-1527.
Article
CAS
PubMed
Google Scholar
Oliver JA, Al-Awqati Q: An endothelial growth factor involved in rat renal development. J Clin Invest. 1998, 102 (6): 1208-1219. 10.1172/JCI785.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nakamura H, Yoshida K, Ikegame K, Kishima Y, Uyama H, Enomoto H: Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis. J Gastroenterol. 2002, 8-14. 37 Suppl 14
Nakamura H, Yoshida K, Kishima Y, Enomoto H, Uyama H, Kuroda T, Okuda Y, Hirotani T, Ito H, Kawase I: Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis. Hepatogastroenterology. 2004, 51 (56): 470-475.
CAS
Google Scholar
Narron JV, Stoops TD, Barringhaus K, Matsumura M, Everett AD: Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration. Pediatr Res. 2006, 59 (6): 778-783. 10.1203/01.pdr.0000219299.24435.4f.
Article
CAS
PubMed
Google Scholar
Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007, 81 (1): 1-5.
Article
CAS
PubMed
Google Scholar
Zong WX, Thompson CB: Necrotic death as a cell fate. Genes Dev. 2006, 20 (1): 1-15. 10.1101/gad.1376506.
Article
CAS
PubMed
Google Scholar
Gallitzendoerfer R, Abouzied MM, Hartmann D, Dobrowolski R, Gieselmann V, Franken S: Hepatoma-derived growth factor (HDGF) is dispensable for normal mouse development. Dev Dyn. 2008, 237 (7): 1875-1885. 10.1002/dvdy.21589.
Article
CAS
PubMed
Google Scholar
Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L: Expression of Hepatoma-Derived Growth Factor Is a Strong Prognostic Predictor for Patients With Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2004, 22 (16): 3230-3237. 10.1200/JCO.2004.02.080.
Article
CAS
PubMed
Google Scholar
Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH: Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer. 2003, 98 (7): 1444-1456. 10.1002/cncr.11653.
Article
CAS
PubMed
Google Scholar
Yoshida K, Tomita Y, Okuda Y, Yamamoto S, Enomoto H, Uyama H, Ito H, Hoshida Y, Aozasa K, Nagano H, Sakon M, Kawase I, Monden M, Nakamura H: Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Ann Surg Oncol. 2006, 13 (2): 159-167. 10.1245/ASO.2006.11.035.
Article
PubMed
Google Scholar
Lepourcelet M, Tou L, Cai L, Sawada J-i, Lazar AJF, Glickman JN, Williamson JA, Everett AD, Redston M, Fox EA, Nakatani Y, Shivdasani RA: Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development. 2005, 132 (2): 415-427. 10.1242/dev.01579.
Article
CAS
PubMed
Google Scholar
Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T, Doki Y, Yoshida K, Aozasa K, Nakamura H, Monden M: Expression of Hepatoma-Derived Growth Factor Is Correlated with Lymph Node Metastasis and Prognosis of Gastric Carcinoma. Clin Cancer Res. 2006, 12 (1): 117-122. 10.1158/1078-0432.CCR-05-1347.
Article
CAS
PubMed
Google Scholar
Yamamoto S, Makuuchi H, Shimada H, Chino O, Nishi T, Kise Y, Kenmochi T, Hara T: Clinical analysis of reflux esophagitis following esophagectomy with gastric tube reconstruction. J Gastroenterol. 2007, 42 (5): 342-345. 10.1007/s00535-007-2011-6.
Article
PubMed
Google Scholar
Uyama H, Tomita Y, Nakamura H, Nakamori S, Zhang B, Hoshida Y, Enomoto H, Okuda Y, Sakon M, Aozasa K, Kawase I, Hayashi N, Monden M: Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res. 2006, 12 (20 Pt 1): 6043-6048.
Article
CAS
PubMed
Google Scholar
Bernard K, Litman E, Fitzpatrick JL, Shellman YG, Argast G, Polvinen K, Everett AD, Fukasawa K, Norris DA, Ahn NG, Resing KA: Functional proteomic analysis of melanoma progression. Cancer Res. 2003, 63 (20): 6716-6725.
CAS
PubMed
Google Scholar
Hu TH, Lin JW, Chen HH, Liu LF, Chuah SK, Tai MH: The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors. Dis Colon Rectum. 2009, 52 (2): 319-326. 10.1007/DCR.0b013e31819d1666.
Article
PubMed
Google Scholar
Ren H, Chu Z, Mao L: Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer. Mol Cancer Ther. 2009, 8 (5): 1106-1112. 10.1158/1535-7163.MCT-08-0779.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Ren H, Yuan P, Lang W, Zhang L, Mao L: Down-regulation of Hepatoma-Derived Growth Factor Inhibits Anchorage-Independent Growth and Invasion of Non-Small Cell Lung Cancer Cells. Cancer Res. 2006, 66 (1): 18-23. 10.1158/0008-5472.CAN-04-3905.
Article
CAS
PubMed
Google Scholar
Machuy N, Thiede B, Rajalingam K, Dimmler C, Thieck O, Meyer TF, Rudel T: A Global Approach Combining Proteome Analysis and Phenotypic Screening with RNA Interference Yields Novel Apoptosis Regulators. Mol Cell Proteomics. 2005, 4 (1): 44-55.
Article
CAS
PubMed
Google Scholar
Shen XY, Zacal N, Singh G, Rainbow AJ: Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol. 2005, 81 (2): 306-313. 10.1562/2004-07-22-RA-242.1.
Article
CAS
PubMed
Google Scholar
Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996, 85 (1): 27-37. 10.1016/S0092-8674(00)81079-X.
Article
CAS
PubMed
Google Scholar
Bancroft JDaC, H C: Manual of histological techniques and their diagnostic application. Churchill Livingstone. 1994
Google Scholar
Fewou SN, Bussow H, Schaeren-Wiemers N, Vanier MT, Macklin WB, Gieselmann V, Eckhardt M: Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase. J Neurochem. 2005, 94 (2): 469-481. 10.1111/j.1471-4159.2005.03221.x.
Article
CAS
PubMed
Google Scholar
Harlow E, Lane D: Antibodies: a laboratory manual. 1988, Cold Spring Habor, NY: Cold Spring Habor Laboratory Press
Google Scholar
Beermann F, Schmid E, Ganss R, Schutz G, Ruppert S: Molecular characterization of the mouse tyrosinase gene: pigment cell-specific expression in transgenic mice. Pigment Cell Res. 1992, 5 (5 Pt 2): 295-299.
Article
CAS
PubMed
Google Scholar
Tief K, Hahne M, Schmidt A, Beermann F: Tyrosinase, the key enzyme in melanin synthesis, is expressed in murine brain. Eur J Biochem. 1996, 241 (1): 12-16. 10.1111/j.1432-1033.1996.0012t.x.
Article
CAS
PubMed
Google Scholar
Tief K, Schmidt A, Aguzzi A, Beermann F: Tyrosinase is a new marker for cell populations in the mouse neural tube. Dev Dyn. 1996, 205 (4): 445-456. 10.1002/(SICI)1097-0177(199604)205:4<445::AID-AJA8>3.0.CO;2-I.
Article
CAS
PubMed
Google Scholar
Tief K, Schmidt A, Beermann F: Regulation of the tyrosinase promoter in transgenic mice: expression of a tyrosinase-lacZ fusion gene in embryonic and adult brain. Pigment Cell Res. 1997, 10 (3): 153-157. 10.1111/j.1600-0749.1997.tb00477.x.
Article
CAS
PubMed
Google Scholar
Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner JW, DePinho RA: Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997, 11 (21): 2822-2834. 10.1101/gad.11.21.2822.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kelsall SR, Mintz B: Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility. Cancer Res. 1998, 58 (18): 4061-4065.
CAS
PubMed
Google Scholar
Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G: Neonatal sunburn and melanoma in mice. Nature. 2001, 413 (6853): 271-272. 10.1038/35095108.
Article
CAS
PubMed
Google Scholar
Thomas J, Liu T, Cotter MA, Florell SR, Robinette K, Hanks AN, Grossman D: Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Res. 2007, 67 (11): 5172-5178. 10.1158/0008-5472.CAN-06-3669.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grote W, Lund OE: Observations on pathogenesis of an unusual intraspinal epidermoid. Dtsch Z Nervenheilkd. 1957, 176 (1): 48-54.
Article
CAS
PubMed
Google Scholar
Sandoval R, Urbina F: Pigmented follicular cyst. Br J Dermatol. 1994, 131 (1): 130-131. 10.1111/j.1365-2133.1994.tb08470.x.
Article
CAS
PubMed
Google Scholar
Shet T, Desai S: Pigmented epidermal cysts. Am J Dermatopathol. 2001, 23 (5): 477-481. 10.1097/00000372-200110000-00015.
Article
CAS
PubMed
Google Scholar
Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W: Cell death in the skin. Apoptosis. 2009, 14 (4): 549-569. 10.1007/s10495-009-0324-z.
Article
PubMed
Google Scholar
Everett AD, Lobe DR, Matsumura ME, Nakamura H, McNamara CA: Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest. 2000, 105 (5): 567-575. 10.1172/JCI7497.
Article
CAS
PubMed
PubMed Central
Google Scholar
Everett AD, Narron JV, Stoops T, Nakamura H, Tucker A: Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am J Physiol Lung Cell Mol Physiol. 2004, 286 (6): L1194-1201. 10.1152/ajplung.00427.2003.
Article
CAS
PubMed
Google Scholar
Enomoto H, Nakamura H, Komatsu-Kanatani N, Liu Y, Yoshida K, Okuda Y, Yamamoto T, Liu W, Nishiguchi S: Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice. World J Hepatol. 2009, 1 (1): 98-102. 10.4254/wjh.v1.i1.98.
Article
PubMed
PubMed Central
Google Scholar
Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl MA, Fajmann S, Grebien F, Warsch W, Stengl G, Hennighausen L, Poli V, Beug H, Moriggl R, Sexl V: Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. EMBO Mol Med. 2010, 2 (3): 98-110. 10.1002/emmm.201000062.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fulda S: Tumor resistance to apoptosis. Int J Cancer. 2009, 124 (3): 511-515. 10.1002/ijc.24064.
Article
CAS
PubMed
Google Scholar
Luo J, Solimini NL, Elledge SJ: Principles of cancer therapy: oncogene and non-oncogene addiction. Cell. 2009, 136 (5): 823-837. 10.1016/j.cell.2009.02.024.
Article
CAS
PubMed
PubMed Central
Google Scholar
Solimini NL, Luo J, Elledge SJ: Non-oncogene addiction and the stress phenotype of cancer cells. Cell. 2007, 130 (6): 986-988. 10.1016/j.cell.2007.09.007.
Article
CAS
PubMed
Google Scholar
Liao F, Dong W, Fan L: Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor. Med Oncol. 2009, 27 (4): 1219-1226.
Article
PubMed
Google Scholar
Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT: Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Apoptosis. 2008, 13 (9): 1135-1147. 10.1007/s10495-008-0241-6.
Article
CAS
PubMed
Google Scholar
Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT: Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells. Cell Physiol Biochem. 2009, 24 (3-4): 253-262. 10.1159/000233250.
Article
CAS
PubMed
Google Scholar